Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors-Reference-Cited by-同舟云学术

Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors

Published:2024-01-15 Issue:3 Volume:204 Page:643-647
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Bang Alexander S.^ORCID,Fay Christopher J.,LeBoeuf Nicole R.,Etaee Farshid,Leventhal Jonathan S.,Sibaud Vincent,Arbesman Joshua,Wang Jennifer Y.,Kwong Bernice Y.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10549-023-07217-2.pdf

Reference14 articles.

1. Spring LM, Wander SA, Andre F, Moy B, Turner NC, Bardia A (2020) Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future. Lancet 395(10226):817–827. https://doi.org/10.1016/S0140-6736(20)30165-3

2. Raschi E, Fusaroli M, La Placa M et al (2022) Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System. Am J Clin Dermatol 23(2):247–255. https://doi.org/10.1007/s40257-021-00645-0

3. Pasqualoni M, Orlandi A, Palazzo A et al (2023) Case report: vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response. Front Oncol 13:1067264. https://doi.org/10.3389/fonc.2023.1067264

4. Chan OB, Su JC, Yazdabadi A, Chan A (2022) Drug induced vitiligo-like depigmentation from a CDK 4/6 inhibitor. Asia Pac J Clin Oncol 18(2):e154–e156. https://doi.org/10.1111/ajco.13585

5. Sollena P, Nikolaou V, Soupos N et al (2021) Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors. Breast Cancer Res Treat 185(1):247–253. https://doi.org/10.1007/s10549-020-05914-w

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abemaciclib-Associated Skin, Hair, and Nail Toxicities: A Case Report;Cureus;2024-04-05